Antibody-drug conjugates in acute myeloid leukemia: Commentary Journal Article
| Authors: | Scheinberg, D. A.; Jurcic, J. G.; Maslak, P. |
| Article Title: | Antibody-drug conjugates in acute myeloid leukemia: Commentary |
| Keywords: | acute granulocytic leukemia; clinical trial; neutropenia; drug efficacy; drug safety; hypertension; monotherapy; liver dysfunction; antineoplastic agent; infection; bone marrow suppression; bleeding; thrombocytopenia; hematopoietic stem cell transplantation; drug selectivity; cancer mortality; cancer resistance; asthenia; chill; drug fever; dyspnea; pneumonia; cause of death; chemotherapy induced emesis; drug response; remission; sepsis; short survey; lactate dehydrogenase; safety; hyperbilirubinemia; leukemia relapse; brain hemorrhage; lactate dehydrogenase blood level; myeloid progenitor cell; multidrug resistance; cd33 antigen; gemtuzumab ozogamicin; liver venoocclusive disease; acute myeloid leukemia; calicheamicin |
| Journal Title: | Nature Clinical Practice Oncology |
| Volume: | 3 |
| Issue: | 5 |
| ISSN: | 1743-4254 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2006-05-01 |
| Start Page: | 238 |
| End Page: | 239 |
| Language: | English |
| DOI: | 10.1038/ncponc0478 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "Source: Scopus" |
